Activated double-negative T cells (CD3+CD4-CD8-HLA-DR+) define response to renal denervation for resistant hypertension

Clin Immunol. 2020 Sep:218:108521. doi: 10.1016/j.clim.2020.108521. Epub 2020 Jun 30.

Abstract

Purpose: To explore the cellular immune response of patients with resistant hypertension treated with renal denervation (RDN).

Methods and results: Twenty-three patients were included and blood samples were obtained in six timings, pre and post procedure. Response was evaluated at six-months and one year and was observed in 69.6% and 82.6% of patients, respectively. Absolute values of HLA-DR+ double negative (DN) T cells were significantly lower in the group of 'responders' at one year, and interaction between the timings were found in three T cell subsets (T CD4, T CD8 and naïve T CD8 cells), with the 'responders' tending to present with lower absolute values and little inter-timing variation.

Conclusions: 'Responders' significantly present with lower absolute values of activated DN T cells and have lower and more stable values of total T CD8+, CD4+, and naïve T CD8+ cells. These cell types may be able to predict response to RDN.

Keywords: Biomarker; Double-negative T cells; Hypertension; Immune system; Inflammation; Renal denervation.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Blood Pressure
  • Catheter Ablation
  • Cytokines / blood
  • Denervation
  • Female
  • Femoral Artery / surgery
  • Humans
  • Hypertension, Renal / blood
  • Hypertension, Renal / immunology*
  • Hypertension, Renal / physiopathology
  • Hypertension, Renal / surgery
  • Kidney / innervation
  • Male
  • Middle Aged
  • T-Lymphocyte Subsets / immunology*
  • Treatment Outcome

Substances

  • Cytokines